Canadian Psychiatric Association
 

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Guest Editorial
Psychiatric Epidemiology in Canada and the CCHS Study

David L Streiner, John Cairney, Alain Lesage

(PDF)


CAPE Special Issue
The Canadian Community Health Survey: Mental Health and Well-Being

Ronald Gravel, Yves Béland

(PDF)

Unmet Need for the Treatment of Depression in Atlantic Canada
Jill M Starkes, Christiane C Poulin, Stephen R Kisely

(PDF)

Area Variations in the Prevalence of Substance Use and Gambling Behaviours and Problems in Quebec: A Multilevel Analysis
Sylvia Kairouz, Louise Nadeau, Géraldine Lo Siou

(PDF)

Is the Statistical Association Between Sex and the Use of Services for Mental Health Reasons Confounded or Modified by Social Anchorage?
Aline Drapeau, Alain Lesage, Richard Boyer

(PDF)

Psychotropic Medication Use in Canada
Cynthia A Beck, Jeanne VA Williams, Jian Li Wang, Aliya Kassam, Nady El-Guebaly, Shawn R Currie, Colleen J Maxwell, Scott B Patten

(PDF)

Service Use for Mental Health Reasons: Cross-Provincial Differences in Rates, Determinants, and Equity of Access
Helen-Maria Vasiliadis, Alain Lesage, Carol Adair, Richard Boyer

(PDF)

Correlates of Depressive and Anxiety Disorders Among Young Canadians
Cat Tuong Nguyen, Louise Fournier, Lise Bergeron, Pasquale Roberge, Geneviève Barrette

(PDF)

Determinants of Service Use Among Young Canadians With Mental Disorders
Emilie Bergeron, Léo-Roch Poirier, Louise Fournier, Pasquale Roberge, Geneviève Barrette

(PDF)

Variations in the Prevalence of Psychiatric Disorders and Social Problems Across Canadian Provinces
Angus H Thompson

(PDF)

Perceived Need for Mental Health Treatment in a Nationally Representative Canadian Sample
Jitender Sareen, Brian J Cox, Tracie O Afifi, Ian Clara, Bo Nancy Yu

(PDF)

Help-Seeking Behaviours of Individuals With Mood Disorders
JianLi Wang, Scott B Patten, Jeanne VA Williams, Shawn Currie, Cynthia A Beck, Colleen J Maxwell, Nady El-Guebaly

(PDF)

Comorbidity of Major Depression With Substance Use Disorders
Shawn R Currie, Scott B Patten, Jeanne VA Williams, JianLi Wang, Cynthia A Beck, Nady El-Guebaly, Colleen Maxwell

(PDF)


CAPE Special Issue

Help-Seeking Behaviours of Individuals With Mood Disorders

JianLi Wang, PhD1, Scott B Patten, MD, FRCPC, PhD2, Jeanne VA Williams, BA, MSc3, Shawn Currie, PhD, RPsych4, Cynthia A Beck, MD, MASc, FRCPC5, Colleen J Maxwell, BSc, MA, PhD6, Nady El-Guebaly, MD FRCPC7

 

Objective: This study had the following objectives: 1) to estimate the 12-month prevalence of conventional and unconventional mental health service use by individuals with major depressive disorder (MDD) or mania in the past year, and 2) to identify factors associated with the use of conventional mental health services by individuals with MDD or mania in the past year.

Method: We examined data from the Canadian Community Health Survey: Mental Health and Well-Being (CCHS 1.2). Respondents with MDD (n = 1563) or manic episodes (n = 393) in the past 12 months were included in this analysis.

Results: An estimated 63.9% of respondents with MDD and 59.0% of those with manic episodes reported having used some type of help in the past 12 months; 52.9% of those with MDD and 49.0% of those with manic episodes used conventional mental health services. Approximately 21% of respondents with either MDD or manic episodes used natural health products specifically for emotional, mental health, and drug or alcohol use problems. Respondents who reported comorbid anxiety disorders and long-term medical conditions were more likely to have used conventional mental health services.

Conclusions: Relative to previous Canadian literature, our analysis suggests that the frequency of conventional mental health service use among persons with MDD has not increased significantly in the past decade. Further, the rate of conventional mental health service use by persons with manic episodes is unexpectedly low. These findings may reflect the lack of national initiatives targeting mood disorders in Canada. They have important implications for planning future education, promotion, and research efforts.

(Can J Psychiatry 2005;50:652–659)

Click here for author affiliations. 

Clinical Implications

  • In Canada, the frequency of conventional mental health service use by persons with MDD has not increased significantly in the past decade.

  • Only 49% of individuals with manic episodes use conventional mental health services.

  • Approximately 21% of individuals with mood disorders use natural health products for emotional, mental health, and drug or alcohol use problems.

Limitations

  • The CCHS 1.2 was a cross-sectional study. The temporal sequence of mood disorders, comorbid physical and mental disorders, and mental health service use was not clear.

  • The CCHS 1.2 relied on self-report. Therefore, reporting and recall bias was possible.

  • The CCHS 1.2 did not collect data about the severity of mental disorders.

Key Words: mental health service use, mood disorder, CCHS 1.2, bipolar disorder, natural health products, major depression

Résumé : Comportements de recherche d’aide des personnes souffrant de troubles de l’humeur



Abbrwang.jpg - 0 Bytes

Mood disorders are prevalent and impose a significant burden on society. Although efficacious treatments have been developed for both unipolar depressive disorder and bipolar disorder (1,2), it is well recognized that many people with MDD in the community do not use mental health services. The Edmonton Survey of Psychiatric Disorders (3) and the Mental Health Supplement to the Ontario Health Survey (the Supplement) (4) examined mental health service use in local populations. Regarding conventional mental health service use among persons with MDD, studies based on these 2 surveys reported a 12-month prevalence of 46.7% (3) and 52.5% (5), respectively. To formulate mental health policy, national-level descriptive data for mental health service use among people with mental disorders are essential (6). However, such data were not available prior to the CCHS 1.2 (7).

Mental health care is primarily provided by mainstream health care professionals. However, persons with mental disorders may also seek help from other sources, including religious advisors or healers and CAM practitioners. Services provided by these professionals for individuals with mental health problems have been broadly referred to as unconventional medicine (8–13). Although the effectiveness of unconventional medicine for the treatment of mental disorders needs to be established, individuals with mental health problems have increasingly used unconventional medical services (11–13). Data from the CCHS 1.2 provided a unique opportunity to examine help-seeking behaviours of people with mental disorders outside the mainstream health system.

Using the data from the CCHS 1.2, our objectives were, first, to estimate the frequency of conventional and unconventional mental health service use in the past 12 months for emotional, mental health, and alcohol or drug use problems among individuals with MDD or manic episodes; and second, to identify factors related to the use of conventional mental health services in individuals with MDD or mania in the past year.

Methods

The CCHS 1.2

Elsewhere in this issue of the CJP, Ronald Gravel discusses in detail the CCHS 1.2 methodology, target population, sampling procedures, response rate, and psychiatric assessment (14).

Help-Seeking Behaviours

Health Professionals. The CCHS 1.2 asked respondents the following question: “Have you ever seen, or talked on the telephone, to any of the following professionals about your emotions, mental health or use of alcohol or drugs?” (referred to thereafter as “mental health problems”). The professionals included psychiatrists, family doctors or general practitioners, other medical doctors, psychologists, nurses, social workers, counsellors or psychotherapists, religious or spiritual advisors, and other professionals. “Other professionals” referred to acupuncturists, biofeedback teachers, chiropractors, energy healing specialists, exercise or movement therapists, herbalists, homeopaths or naturopaths, hypnotists, guided imagery specialists, massage therapists, relaxation experts, yoga or meditation experts, and dieticians.

Other Help. In addition to health professionals, the CCHS 1.2 collected information about whether respondents had used an Internet support group or chat room, a self-help group, or a telephone helpline for mental health problems.

Natural Health Products. The CCHS 1.2 respondents were presented with the following statement and question: “Many people use other health products such as herbs, minerals or homeopathic products for problems with emotions, alcohol or drug use, energy, concentration, sleep or ability to deal with stress. In the past 12 months, have you used any of these health products?” The Statistics Canada document lists in detail the names of the health products referred to (7).

Classification of Service Use. To be consistent with the previous studies (8–13), in this analysis we defined contact in the past 12 months with a psychiatrist, a psychologist, other medical doctors, a nurse, a social worker or a therapist for mental health problems as the use of conventional mental health services. The use of unconventional health services means contacts with religious advisors or CAM practitioners. The use of Internet support, self-help groups, or telephone helplines does not fit well with either type of service as described above. In this analysis, the results of using these latter types of help are presented separately. Regarding natural health products, previous studies of CAM service use for mental health problems focused mainly on the services provided by CAM practitioners (10–13,15). For comparison, the results related to the use of natural health products are also presented separately.

Demographic variables are included in this analysis (specifically, sex, age, marital status, levels of family income and education, and rural or urban residence), as are clinical variables (specifically, long-term medical conditions, role interference, suicide attempts in the past 12 months, comorbid anxiety disorders, and comorbid alcohol and illicit drug dependence). The CCHS 1.2 respondents who passed the screener for depression were administered the Sheehan Disability Scale (16) to assess the extent to which a particular mental disorder interfered with functioning at work, in the household, in relationships, and in social roles in the worst month of the past year. Responses were scored with a 0-to-10 VAS. Statistics Canada defined a score of 4 or more on the scale as severe role interference or functional impairment (7).

Statistical Analysis

Respondents who had MDD, that is, those who had major depressive episode(s) without lifetime mania (n = 1563) and those with manic episodes (n = 393), were included in this analysis. To be consistent with the timeframe of mental health service use (that is, the past 12 months), the occurrence of MDD and manic episodes referred to the preceding year. We estimated the proportions using various services in the past 12 months separately for these 2 groups.

The use of conventional mental health services has direct policy and service planning implications. Therefore, we focused on identifying factors associated with conventional mental health service use. The proportions of those with mood disorders using conventional mental health services were estimated by demographic and clinical variables. Logistic regression modelling was used to identify factors associated with the use of conventional mental health services. Because the CCHS 1.2 used complex sampling procedures, we used sampling weights and bootstrap weights endorsed by Statistics Canada to estimate the proportions and to calculate associated 95%CI. This analysis was carried out using SAS 8.0 (17).

Results

Table 1 shows the proportions of respondents with MDD and manic episodes who used various services in the past 12 months for mental health problems. Among respondents with MDD, 63.9% used some help, mainly from conventional mental health care providers (52.9%). Only 6.1% reported having used services from religious advisors or CAM practitioners. Respondents who attended self-help groups or used Internet chat rooms or telephone helplines accounted for 10.5% of those with MDD. Twenty-two percent reported that they had used natural health products for their mental health problems. We observed similar patterns of health service use among respondents with manic episodes. Respondents with manic episodes did not differ from those with MDD in use of any help (59.0%), in use of conventional health services (49.0%), in use of unconventional health services (9.3%), in use of natural health products (21.1%), and in use of other services (12.5%).

Table 1  The frequency of mental health service use by individuals with MDD and manic episodes in the past 12 months 


Services 

With MDDa
n = 1563
Weighted % (95%CI) 

With manic episodes
n = 393
Weighted % (95%CI) 


Conventional Services 

52.9 (49.3 to 56.5) 

49.0 (42.4 to 55.6) 

     Psychiatrists 

17.9 (15.3 to 20.6) 

23.3 (17.6 to 29.1) 

     Psychologists 

13.6 (11.2 to16.0) 

10.8 (6.6 to 15.1)b 

     Other MDs 

40.8 (37.1 to 44.4) 

37.6 (31.3 to 43.9) 

     Nurses 

4.2 (2.9 to 5.4) 

6.8 (4.0 to 9.6)b 

     Social Workers 

14.7 (12.0 to 17.5) 

17.3 (12.3, 22.3) 

Unconventional Services 

6.1 (4.6 to 7.5) 

9.3 (5.4 to 13.2)b 

     Religious Advisors 

4.5 (3.2 to 5.7)b 

8.2 (4.4 to 12.0)b 

     CAM Practitioners 

1.9 (1.0 to 2.8)b 

 

Natural Health Products 

22.0 (19.1 to 24.9) 

21.1 (16.1 to 26.0) 

Other Services 

10.5 (8.3 to 12.7) 

12.5 (8.3 to 16.8)b 

     Self-help groups 

7.2 (5.3 to 9.0) 

7.3 (4.0 to 10.5)b 

     Internet chat rooms 

1.7 (0.9 to 2.5)b 

 

     Telephone helplines 

2.7 (1.7 to 3.7)b 

4.9 (2.5 to 7.3)b 

Any Help 

63.9 (60.5 to 67.4) 

59.0 (52.4 to 65.7) 

Any Help Excluding 

54.9 (51.3 to 58.5) 

51.0 (44.3 to 57.6) 

Natural Health Products 

   

aIndividuals who had had a major depressive episode in the past 12 months, excluding those with lifetime manic episodes 

bBootstrap coefficient of variance between 16.6% and 33.3% 

Other MDs = family doctors, general practitioners, and other medical doctors 

We examined the natural health products frequently used for mental health problems. Table 2 lists the 3 most frequently used health products in each group. Vitamins were most frequently used, followed by St John’s wort and ginseng. The use of St John’s wort did not differ from that of ginseng, regardless of the disorder. Respondents with MDD were more likely to use vitamins than were those with manic episodes. Among respondents with MDD, more used vitamins than St John’s wort and ginseng.

Table 2  Top 3 natural health products used for emotional and mental health problems in participants with MDD and manic episodes in the past 12 months 


Products 

With MDDa
n
= 1563
Weighted % (95%CI) 

With manic episodes
n = 393
Weighted % (95%CI) 


Vitamins 

12.7 (10.2 to 15.2) 

9.2 (5.6 to 12.8)

St John’s wort 

4.2 (2.8 to 5.6)b 

4.8 (2.1 to 7.5)b 

Ginseng 

3.4 (2.2 to 4.5)b 

4.6 (2.3 to 7.0)b 


aIndividuals who had had a major depressive episode in the past 12 months, excluding those with lifetime manic episodes 

bBootstrap coefficient of variance between 16.6% and 33.3% 

Table 3 shows the estimated frequencies of conventional mental health service use among individuals with different demographic and clinical characteristics. Among respondents with MDD, the use of conventional mental health services did not differ by sex, marital status, family income and educational levels, or rural–urban areas. Those aged 26 to 45 years were more likely to use mental health services than were the youngest group. Individuals who reported having one or more long-term medical conditions, severe role interference, suicide attempts, comorbid anxiety disorders, or any comorbid disorders in the preceding year were more likely to use conventional mental health services. Conventional mental health service use was not related to having comorbid substance use disorders.

Table 3  The frequency of conventional mental health service use by demographic and clinical variables among those with MDD and manic episodes in the past 12 months 


Variables 

With MDDa
% (95%CI) 

With Manic Episodes
% (95%CI) 


Demographics 

   

     Men 

48.8 (42.3 to 55.2) 

44.5 (34.9 to 54.1) 

     Women 

55.2 (50.8 to 59.6) 

53.3 (44.0 to 62.7) 

     Aged 15 to 25 years 

41.9 (34.5 to 49.2) 

36.8 (26.1 to 47.6) 

     Aged 26 to 45 years 

58.6 (53.4 to 63.8) 

50.7 (41.2 to 60.2) 

     Aged 46+ years 

52.9 (46.3 to 59.5) 

65.0 (50.8 to 79.3) 

     Married, common law,      partnership 

51.1 (45.1 to 57.2) 

51.4 (40.3 to 62.4) 

     Single 

54.7 (49.4 to 60.1) 

41.5 (31.9 to 51.0) 

     Divorced, separated, widowed 

52.2 (44.6 to 59.7) 

62.0 (47.3 to 77.1) 

     Low family income 

55.4 (50.6 to 60.1) 

50.1 (40.8 to 59.4) 

     Middle–high income 

53.2 (47.4 to 58.9) 

51.4 (41.5 to 61.4) 

     £ 13 years education 

50.3 (45.1 to 55.4) 

38.6 (29.1 to 48.0) 

     > 13 years education 

54.8 (49.4 to 60.2) 

60.1 (50.9 to 69.2) 

     Rural areas 

47.8 (37.1 to 57.8) 

38.0 (20.9 to 55.1) 

     Urban areas 

53.8 (50.1 to 57.7) 

51.0 (44.0 to 58.0) 

Clinical Variables 

   

     Long-term medical conditions 

   

          Yes 

56.5 (52.5 to 60.5) 

53.5 (46.4 to 60.6) 

          No 

32.4 (24.3 to 40.4) 

19.5 (7.3 to 31.8) 

     Severe role interference 

   

          Yes 

55.0 (51.3 to 58.8) 

48.4 (41.7 to 55.2) 

          No 

31.9 (19.8 to 44.0) 

 

     Suicide attempts 

   

          Yes 

71.3 (55.1 to 87.5) 

62.9 (39.8 to 86.0) 

          No 

52.3 (48.7 to 55.9) 

47.3 (40.6 to 54.1) 

     Comorbid anxiety disorders 

   

          Yes 

66.5 (58.3 to 74.8) 

60.4 (50.5 to 70.3) 

          No 

48.8 (44.7 to 52.9) 

38.1 (29.0 to 47.3) 

     Comorbid substance use      disorders 

   

          Yes 

55.5 (43.9 to 67.1) 

46.5 (33.5 to 59.5) 

          No 

44.5 (32.9 to 56.1) 

49.8 (42.0 to 57.6) 

     Any comorbid disorders 

   

          Yes 

65.0 (56.9 to 73.2) 

55.8 (47.6 to 63.9) 

          No 

48.8 (44.6 to 53.0) 

32.5 (20.3 to 44.6) 


aIndividuals who had had a major depressive episode in the past 12 months, excluding those with lifetime manic episodes 

We observed a similar pattern among those with manic episodes, except that the proportions of conventional mental health service use in the group with 13 or more years of education (60.1%) and in the group aged 46 years or older (65%) were higher than proportions in the group of respondents with less education (38.6%) and in the youngest group (36.8%). Respondents who reported suicide attempts appeared to be more likely to use conventional mental health services than those who did not report suicide attempts.

We used logistic regression modelling to identify clinical factors associated with the use of conventional mental health services, controlling for the effects of demographic and socioeconomic characteristics. In logistic regression modelling, we analyzed age as a continuous variable. In the models, preliminary analysis found large bootstrap coefficients of variance associated with family income levels, rural or urban residence, severe role interference, and suicide attempts. To be consistent with Statistics Canada guidelines, we did not include these variables in the final models. In the multivariate analysis, the association between having one or more long-term medical conditions together with comorbid anxiety disorders and conventional mental health service use persisted, regardless of having MDD or manic episodes (Table 4).

Table 4  Results of logistic regression modelling for the use of conventional mental health services in participants with MDD or manic episodesa 


Variables 

With MDDb
OR (95%CI) 

With Manic Episodes
OR (95%CI) 


Long-term chronic conditions 

2.91 (2.48, 3.43) 

3.14 (2.69, 3.68) 

Comorbid anxiety disorders 

5.35 (4.43, 6.46) 

6.12 (5.20, 7.22) 


aControlling for the effects of sex, age, marital status, and educational levels. Age was analyzed as a
continuous variable. 

bIndividuals who had had a major depressive episode in the past 12 months, excluding those with lifetime manic episodes 

Discussion

We found that 63.9% of respondents with MDD and 59.0% of those with manic episodes had used some type of help in the preceding year. Respectively, 52.9% and 49.0% of these 2 groups used conventional mental health services. The lower rate of conventional mental health service use among those with manic episodes was unexpected. Unlike unipolar depression, bipolar disorder is typically treated in the mental health specialty sector (18). The CCHS 1.2 data showed that help-seeking behaviours among respondents with manic episodes resembled those observed in subjects with MDD. One possible explanation is that, unlike MDD, manic symptoms are not easily recognized by the general public. Some may not consider elevated or expansive mood to be psychiatric symptoms, leading to delayed mental health service use or to no use.

Worldwide, treatment-seeking rates for major depression appear to be increasing over time (19). Compared with the findings from the Edmonton study (46.7%) (3) and from the Supplement study (52.5%) (5), the CCHS 1.2 data suggest that the frequency of conventional mental health service use in persons with MDD has not increased significantly in the past decade. This finding is consistent with a study based on data from the National Population Health Survey (20) and a recent study in the UK (21). There may be many reasons for this. The findings from the Edmonton study and the Supplement have been widely disseminated in Canada, but there have been no efforts to implement national initiatives similar to the Major Depression Screening Day in the US (22), the Defeat Depression Campaign in the UK (23), and the SPHERE project in Australia (24).

The rate of using any help reported in the CCHS 1.2 was slightly higher than that reported in the US NCS-R (57.3%) (25). The rates of using conventional mental health services in the NCS-R and in our analysis resembled each other (51.6% and. 52.9%, respectively). The rate was higher than that reported by the recent European Study of the Epidemiology of Mental Disorders project (36.5%) (26). However, the NCS-R reported a higher rate of specialty service use (31.6%) and a lower rate of general medical service use (27.2%) than our analysis.

Previous studies reported that a significant proportion of individuals with mental health problems used CAM services (12,13,15). Using a similar definition of CAM services, the CCHS 1.2 data indicated that only a small proportion of those with mood disorders used these services: only 1.9% of those with MDD used CAM practitioners, which is lower than the use of other services in this population (that is, self-help groups, Internet chat rooms, and telephone helplines). One explanation is that, in Canada, people with mood disorders do not use services provided by CAM practitioners specifically for mental health problems. Alternatively, the low rate might be due to the phrasing of the CCHS 1.2 questions. For the question “Have you ever seen, or talked on the telephone, to any of the following professionals . . .” CAM practitioners were included among other professionals at the end of the question. Because of this placing, some respondents who had actually used CAM services for their mental health problems might have ignored the choice, leading to an underestimated prevalence of unconventional service use.

Univariate analysis showed that the prevalence of conventional mental health service use did not differ by demographic and socioeconomic characteristics among respondents with MDD. Respondents aged 26 to 45 years appeared to have a higher prevalence of conventional mental health service use. These results were consistent with the findings from the Supplement study (5). Among those with manic episodes, there was a trend for the prevalence of conventional mental health services increased with age. Those with 13 or fewer years of education were less likely to have used conventional mental health services. The remaining demographic and socioeconomic variables were not associated with conventional mental health service use in respondents with manic episodes.

Respondents who reported one or more long-term medical conditions, severe role interference, suicide attempts, and comorbid anxiety disorders had a higher prevalence of conventional mental health service use, regardless of having MDD or manic episodes. The association between long-term medical conditions together with comorbid anxiety disorders and conventional mental health service use persisted in multivariate analysis. This was consistent with clinical expectations. However, having comorbid substance use disorders was not related to conventional mental health service use in these 2 groups. It was not clear why comorbid alcohol or illicit drug dependence did not affect service use in these 2 groups. Perhaps this finding is due to regional variations in the degree to which addiction and mental health services are integrated. It may also reflect a treatment culture that manages individuals with comorbid substance use disorders in separate services.

Our analysis had several limitations. First, the CCHS 1.2 was a cross-sectional study. The temporal sequence of mood disorders, comorbid physical and mental disorders, and mental health service use was not clear. Second, the CCHS 1.2 relied on self-report. Thus reporting and recall bias was possible. Third, the CCHS 1.2 did not collect data that allowed us to assess how severity levels were related to mental health service use. Finally, we could not assess treatment quality, since data on medication dosage and treatment duration were not collected.

Within the context of these limitations, results of our study suggest that people with mood disorders seek help from various sources. Clinical factors are more strongly associated with conventional mental health service use than are demographic and socioeconomic factors. Policy-makers, mental health service planners, and clinicians should be aware that natural health products are frequently used in this population. More studies are needed to determine the risks and benefits of natural health products for treating mood disorders.

Funding and Support

This research was supported by a grant from the CIHR (grant 119681). Dr Wang holds a New Investigator Award from the CIHR. Dr Patten is a Health Scholar with the Alberta Heritage Foundation for Medial Research and a Fellow with the Institute of Health Economics. Dr Beck holds a Fellowship from the CIHR and a Clinical Fellowship from the Alberta Heritage Foundation for Medical Research. Dr Maxwell is funded by a New Investigator Award from the CIHR Institute of Aging and a Population Health Investigator Award from the Alberta Heritage Foundation for Medical Research; she is also a Fellow with the Institute of Health Economics in Edmonton, Alberta.

Acknowledgements

The research and data analysis used data from Statistics Canada. However, the opinions and views expressed do not represent those of Statistics Canada.


References

1. Parikh SV, Lam RW, CANMAT Depression Working Group. Clinical guidelines for the treatment of depressive disorders. I. Definitions, prevalence, and health burden. Can J Psychiatry 2001;46(Suppl 1):13S–20S.

2. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder (revision). American Psychiatric Association. Arlington (VA); 2002.

3. Bland RC, Newman SC, Orn H. Help-seeking for psychiatric disorders. Can J Psychiatry 1997;42:935–42.

4. Boyle MH, Offord DR, Campbell D, Catlin G, Goering P, Lin E, and others. Mental health supplement to the Ontario Health Survey: methodology. Can J Psychiatry 1996;41:549–58.

5. Lin E, Parikh SV. Sociodemographic, clinical, and attitudinal characteristics of the untreated depressed in Ontario. J Affect Disord 1999;53:153–62.

6. World Health Organization. The World Health Report 2001. Mental health: new understanding, new hope. Geneva: World Health Organization; 2001.

7. Statistics Canada. Canadian Community Health Survey Mental Health and Well-Being. Ottawa (ON): Statistics Canada. 2004 Catalogue nr 82-617-XIE. Available: www.statcan.ca/english/freepub/82-617-XIE/free.htm. Accessed 2005 June 29.

8. Gevitz N. Three perspectives on unorthodox medicine. In: Gevitz N, editor. Other healers: unorthodox medicine in America. Baltimore (MD): Johns Hopkins University Press; 1988:1–28.

9. Kaptchuk TJ, Eisenberg DM. Varieties of healing. 2: a taxonomy of unconventional healing practices. Ann Intern Med 2001;135:196–204.

10. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246–52.

11. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, and others. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569–75.

12. Unutzer J, Klap R, Sturm R, Young AS, Marmon T, Shatkin J, and others. Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry 2000;157:1851–7.

13. Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MI, and others. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 2001;158:289–94.

14. Gravel R, Béland Y. The Canadian Community Health Survey: Mental Health and Well-Being. Can J Psychiatry 2005;50:573–9.

15. Wang JL, Patten SB, Russell ML. Alternative medicine use by individuals with major depression. Can J Psychiatry 2001;46:528–33.

16. Leon AC, Olfsen M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997;27:93–105.

17. The SAS system for Windows. Cary (NC): The SAS Institute; 2004.

18. Bauer M, Unutzer J, Pincus HA, Lawson WB, NIMH Affective Disorders Work Group. Bipolar disorder. Ment Health Serv Res 2002;4:225–9.

19. Bristow K, Patten SB. Treatment-seeking rates and associated mediating factors among individuals with depression. Can J Psychiatry 2002;47:660–5.

20. Patten SB, Beck C. Major depression and mental health care utilization in Canada: 1994 to 2000. Can J Psychiatry 2004;49:303–9.

21. Brugha TS, Bebbington PE, Singleton N, Melzer D, Jenkins R, Lewis G, and others. Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry 2004;185:378–84.

22. Jacobs DG. National Depression Screening Day: educating the public, reaching those in need of treatment, and broadening professional understanding. Harv Rev Psychiatry 1995;3:156–9.

23. Paykel ES, Tylee A, Wright A, Priest RG, Rix S, Hart D. The Defeat Depression Campaign: psychiatry in the public arena. Am J Psychiatry 1997;154:59–65.

24. Hickie IB, Davenport TA, Naismith SL, Scott EM. SPHERE: a national depression project. SPHERE National Secretariat. Med J Aust 2001;175 Suppl:S4–S5.

25. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, and others; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–105.

26. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, and others; ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of MentalDisorders (ESEMeD) Project. Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:47–54.

Author(s)

Manuscript received and accepted May 2005.
Previously presented in part at the Canadian Academy for Psychiatric Epidemiology Annual Scientific Symposium; 2004 October 14; Montreal (QC).

1. Assistant Professor, Departments of Psychiatry and Community Health Sciences, University of Calgary, Calgary, Alberta.

2. Associate Professor, Departments of Community Health Sciences and Psychiatry, University of Calgary, Calgary, Alberta.

3. Research Assistant, Department of Community Health Sciences, University of Calgary, Calgary, Alberta

4. Adjunct Associate Professor, Departments of Psychology and Psychiatry, University of Calgary, Calgary, Alberta.

5. Clinical Assistant Professor, Department of Psychiatry, University of Calgary, Calgary, Alberta

6. Associate Professor, Departments of Community Health Sciences and Medicine, University of Calgary, Calgary, Alberta.

7. Professor, Department of Psychiatry, University of Calgary, Calgary, Alberta

Address for correspondence: Dr JL Wang, Department of Psychiatry, Room 3645, Peter Lougheed Centre, 3500-26 Av. NE, Calgary, AB

e-mail: jianli.wang@calgaryhealthregion.ca

1 | 2


CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2001 | Index RCP des auteurs 2001
Author Index to 2002 | Index RCP des auteurs 2002
Author Index to 2003 | Index RCP des auteurs 2003
Author Index to 2004 | Index RCP des auteurs 2004
Subject Index to 2001 | Index RCP des sujets 2001
Subject Index to 2002 | Index RCP des sujets 2002
Subject Index to 2003 | Index RCP des sujets 2003
Subject Index to 2004 | Index RCP des sujets 2004
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil